Zeggari M, Esteve J P, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle J A, Vaysse N, Susini C
INSERM U151, CHU Rangueil, Toulouse, France.
Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):441-8. doi: 10.1042/bj3030441.
We have previously shown that somatostatin promotes the stimulation of a membrane tyrosine phosphatase activity in pancreatic cells. To gain insight into the mechanism of somatostatin action, we purified somatostatin-receptor complexes from somatostatin 28-prelabelled rat pancreatic plasma membranes by immunoaffinity chromatography using immobilized antibodies raised against the N-terminal part of somatostatin 28, somatostatin 28 (1-14), which is not involved in receptor-binding-site recognition. After SDS gel electrophoresis a band with a molecular mass of 87 kDa was identified in the affinity-purified material as the somatostatin receptor. The 87 kDa protein was not observed when the membrane receptors were solubilized in a free unoccupied or somatostatin 14-occupied form, or when nonimmune serum replaced the anti-[somatostatin 28 (1-14)] anti-serum. Somatostatin 14 inhibited the appearance of the 87 kDa protein in the same range of concentrations that inhibit radioligand binding on pancreatic membranes. After somatostatin 28 treatment of membranes, purified somatostatin receptor preparations exhibited an elevated tyrosine phosphatase activity that dephosphorylated phosphorylated epidermal growth factor receptor and poly(Glu,Tyr). This activity was related to the presence of somatostatin receptors in purified material. It was increased by dithiothreitol and inhibited by orthovanadate. In purified material containing somatostatin receptors, anti-[Src homology 2 domains (SH2)]-containing tyrosine phosphatase SHPTP1 polyclonal antibodies identified a protein of 66 kDa which was not detected in the absence of somatostatin receptor. Furthermore, the anti-SHPTP1 antibodies immunoprecipitated specific somatostatin receptors from somatostatin-prelabelled pancreatic membranes and from untreated membranes. These results indicate that a 66 kDa tyrosine phosphatase related to SHPTP1 co-purifies with the pancreatic somatostatin receptors, and suggest that this protein is associated with somatostatin receptors at the membrane level.
我们之前已经表明,生长抑素可促进胰腺细胞中膜酪氨酸磷酸酶活性的刺激。为深入了解生长抑素的作用机制,我们使用针对生长抑素28(1 - 14)N端部分产生的固定化抗体,通过免疫亲和层析从生长抑素28预标记的大鼠胰腺质膜中纯化生长抑素受体复合物,生长抑素28(1 - 14)不参与受体结合位点的识别。SDS凝胶电泳后,在亲和纯化的物质中鉴定出一条分子量为87 kDa的条带为生长抑素受体。当膜受体以游离未占据或生长抑素14占据的形式溶解时,或者当非免疫血清替代抗[生长抑素28(1 - 14)]抗血清时,未观察到87 kDa的蛋白质。生长抑素14在抑制胰腺膜上放射性配体结合的相同浓度范围内抑制87 kDa蛋白质的出现。用生长抑素28处理膜后,纯化的生长抑素受体制剂表现出升高的酪氨酸磷酸酶活性,该活性可使磷酸化的表皮生长因子受体和聚(Glu,Tyr)去磷酸化。这种活性与纯化物质中生长抑素受体的存在有关。它被二硫苏糖醇增强,被原钒酸钠抑制。在含有生长抑素受体的纯化物质中,抗[Src同源2结构域(SH2)]酪氨酸磷酸酶SHPTP1多克隆抗体鉴定出一种66 kDa的蛋白质,在没有生长抑素受体的情况下未检测到。此外,抗SHPTP1抗体从生长抑素预标记的胰腺膜和未处理的膜中免疫沉淀特异性生长抑素受体。这些结果表明,与SHPTP1相关的66 kDa酪氨酸磷酸酶与胰腺生长抑素受体共纯化,并表明该蛋白质在膜水平与生长抑素受体相关。